News|Articles|October 20, 2026

DIA LC–MS/MS Maps Proteins in Human Thighbone

Author(s)John Chasse

Data-independent acquisition (DIA) liquid chromatography-tandem mass spectrometry (LC–MS/MS) reveals shared and site-specific proteins across the thighbone.

Studying the proteins found directly in bone could help scientists understand what goes wrong at the molecular level in bone diseases. Until now, most research in people has relied on blood samples instead. In this small early-stage study, researchers compared the proteins in three medically important parts of the thighbone, or femur: the rounded head that fits into the hip socket, the narrow neck just below it, and a bony bump further down called the trochanter. The samples came from people with osteoarthritis who were having hip replacement surgery. The neck was made up mostly of hard, dense outer bone, the head was mostly lighter, spongy inner bone, and the trochanter contained a mix of both. The researchers analyzed the bone samples, along with matching blood samples from the same patients, using a high-throughput data-independent acquisition (DIA) liquid chromatography-tandem mass spectrometry (LC–MS/MS). A paper based on this study was published in the journal Bone Reports.1

Why Is It Important to Understand What Happens to Bones at the Molecular Level?

Bones do much more than hold us up. They let us walk and move, protect our internal organs, and store minerals and hormones the body needs. As people age, their bones can thin out faster than normal, which can lead to osteoporosis, a condition that weakens bones and affects more than 200 million people worldwide.2The lasting disability and higher risk of death that come with weakened bones, especially after a broken hip, place a heavy burden on health systems around the world.3Bones can also be harmed by other health problems. Long-term kidney and gut diseases, poor nutrition, and many common medicines taken for conditions unrelated to bone can all cause bone loss and lead to osteoporosis.4“Therefore,” wrote the authors of the paper,1 “it is vital to improve our understanding of the molecular mechanisms of bone disease.”

What Did the Researchers Learn About the Proteins in Different Parts of the Thighbone?

The researchers found that the bone and bone marrow analyzed turned out to contain a much richer mix of proteins than blood, with 3085 proteins detected in bone compared with 597 in blood. Most of the proteins linked to specific cell types were similar across all three parts of the thighbone and in every patient. These included cells that build and maintain bone, fat cells, stem cells that can become different tissue types, and blood and immune cells. All these looked different from what was found in blood. Although most of the bone's protein makeup was the same no matter where the sample came from, a closer look showed that each part of the thighbone had its own distinctive set of proteins and related biological activities, and these site-specific patterns were strikingly similar from one person to the next.1

“These findings,” write the authors of the paper,1 “suggest that anatomically adjacent femoral sites share a conserved core bone proteome while maintaining distinct molecular characteristics of potential functional relevance. With validation in larger cohorts, the results will contribute to the development of a human bone tissue proteomics atlas providing novel insight in the molecular microarchitecture and functionality relevant for bone health.”

Read More on Similar Topics
LC-MS/MS Mapping of Glucosepane and Pentosidine Crosslinks in Human Bone Collagen

References

  1. Yu, F.; Reppe, S.; Gautvik, V. T. et al. Pilot Proteomics Study of Three Different Human Femur Sites and Autologous Serum Samples. Bone Rep. 2026, 31, 101949. DOI: 10.1016/j.bonr.2026.101949
  2. Sözen, T.; Özışık, L.; Başaran, N. Ç. An Overview and Management of Osteoporosis. Eur J Rheumatol. 2017, 4 (1), 46-56. DOI: 10.5152/eurjrheum.2016.048
  3. Cauley, J. A. Public Health Impact of Osteoporosis. J Gerontol A Biol Sci Med Sci. 2013, 68 (10), 1243-1251. DOI: 10.1093/gerona/glt093
  4. Panday, K.; Gona, A.; Humphrey, M. B. Medication-induced Osteoporosis: Screening and Treatment Strategies. Ther Adv Musculoskelet Dis. 2014, 6 (5), 185-202. DOI: 10.1177/1759720X14546350

Related to this article